Modalis Therapeutics Corporation
Notice Regarding Large-Scale Exercise and Monthly Exercise Status of the 19th Stock Acquisition Rights Issued by Third-Party Allotment (with Exercise Price Adjustment Clause)
Announcement of a large-scale exercise of stock acquisition rights and disclosure of monthly and cumulative exercise status. Total issued units are 240,000; the recent large-scale exercise was 26,700 units (11.1%), and monthly exercise amounted to 71,700 units (29.9%). Unexercised rights remain outstanding.
Key Figures
- Total number of stock acquisition rights issued: 240,000 shares
- Number exercised this time: 26,700 units
- Monthly exercised number: 71,700 units
AI要約
Large-Scale Exercise Status of Stock Acquisition Rights
The subject stock acquisition rights (19th series, with exercise price adjustment clause) were issued by allotment to EVO FUND, and a large-scale exercise of the rights was observed between September 11, 2026 and September 30, 2026. Against the total issuance of 240,000 units, the recent exercise amounted to 26,700 units (11.1%), and monthly exercise reached 71,700 units (29.9%), marking a high level. Unexercised rights stood at 67,000 units at the end of the month.
Future Impact and Exercise Restriction Status
This exercise may contribute to dilution relative to the total issuance; however, compliance with exercise restrictions at present is disclosed as 7.4% based on listing regulations. Future exercise trends are TBD, and additional disclosures are planned.
Modalis Therapeutics Corporation
Company overview · Stock price · Financial data · All IR
